SCHEMBL1609495

SCHEMBL1609495

O=C(C#CCOCc1ccccc1)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MMP2 P08253 2/20 0.50
MMP12 P39900 2/20 0.50
CES1 P23141 4/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
TSHR P16473 1/20 0.44
LMNA P02545 1/20 0.42
FAAH O00519 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610702 0.91 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MMP2MMP12CES1
SCHEMBL534139 0.86 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2MMP2MMP12TSHR
SCHEMBL534570 0.84 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MMP2MMP12TSHR
SCHEMBL16636936 0.84 HDAC3 (0.54) ALDH1A1SMN1; SMN2MMP2MMP12CES1
Trifluoroacetic Acid SCHEMBL27579421 0.77 TSHR (0.62) ALDH1A1CES1TSHRFAAH
SCHEMBL6508653 0.76 TSHR (0.67) ALDH1A1SMN1; SMN2MMP2MMP12TSHR
SCHEMBL31723025 0.74 CES1 (0.60) ALDH1A1CES1HDAC1HDAC2TSHR
SCHEMBL9738326 0.73 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MMP2MMP12TSHR
SCHEMBL9738316 0.73 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MMP2MMP12TSHR
SCHEMBL9738613 0.72 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2MMP2MMP12CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3130094-A None JP disclosed
US-9340526-B2 Process for preparing pyridyl-substituted pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-17 US disclosed
US-20150191447-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-07-09 US disclosed
US-8987460-B2 Process for preparing pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2015-03-24 US disclosed
EP-2414345-B1 Method for manufacturing Pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2014-09-17 EP disclosed
US-20130131347-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-23 US disclosed
US-8362261-B2 Process for preparing pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2013-01-29 US disclosed
US-20120136156-A2 PROCESS FOR PREPARING PYRIDYL-SUBSTITUTED PYRAZOLES BAYER CROPSCIENCE AG (DE) 2012-05-31 US disclosed
US-20110087029-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER CROPSCIENCE AG (DE) 2011-04-14 US disclosed
EP-2243777-A1 Method for manufacturing Pyridyl-substituted pyrazoles Bayer CropScience AG (DE) 2010-10-27 EP disclosed
US-5097075-A 1,1,1-TRIFLUORO-2-HYDROXY COMPOUND SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) 1992-03-17 US disclosed
JP-H03130094-A OPTICALLY ACTIVE PROPARGYL ALCOHOL CONTAINING TRIFLUOROMETHYL GROUP SHOWA SHELL SEKIYU KK 1991-06-03 JP disclosed
EP-0423992-A1 1,1,1-Trifluoro-2-hydroxy compound Showa Shell Sekiyu Kabushiki Kaisha (JP) 1991-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131347-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 ALDH1A1 715/4885SMN1; SMN2 4424/4885MMP2 3741/4885
US-20150191447-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 ALDH1A1 715/4885SMN1; SMN2 4424/4885MMP2 3741/4885
US-20110087029-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 ALDH1A1 715/4885SMN1; SMN2 4424/4885MMP2 3741/4885
US-20120136156-A2 PROCESS FOR PREPARING PYRIDYL-SUBSTITUTED PYRAZOLES PDXK, PLK2, WNK3 ALDH1A1 715/4885SMN1; SMN2 4424/4885MMP2 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.